Product NDC: | 52125-640 |
Proprietary Name: | medroxyprogesterone acetate |
Non Proprietary Name: | MEDROXYPROGESTERONE ACETATE |
Active Ingredient(s): | 150 mg/mL & nbsp; MEDROXYPROGESTERONE ACETATE |
Administration Route(s): | INTRAMUSCULAR |
Dosage Form(s): | INJECTION, SUSPENSION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 52125-640 |
Labeler Name: | REMEDYREPACK INC. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA020246 |
Marketing Category: | NDA AUTHORIZED GENERIC |
Start Marketing Date: | 20130530 |
Package NDC: | 52125-640-01 |
Package Description: | 1 mL in 1 VIAL (52125-640-01) |
NDC Code | 52125-640-01 |
Proprietary Name | medroxyprogesterone acetate |
Package Description | 1 mL in 1 VIAL (52125-640-01) |
Product NDC | 52125-640 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | MEDROXYPROGESTERONE ACETATE |
Dosage Form Name | INJECTION, SUSPENSION |
Route Name | INTRAMUSCULAR |
Start Marketing Date | 20130530 |
Marketing Category Name | NDA AUTHORIZED GENERIC |
Labeler Name | REMEDYREPACK INC. |
Substance Name | MEDROXYPROGESTERONE ACETATE |
Strength Number | 150 |
Strength Unit | mg/mL |
Pharmaceutical Classes | Progesterone Congeners [Chemical/Ingredient],Progestin [EPC] |